Latest filing published 26 Feb 2020 for Madrigal Pharmaceuticals, INC., €1.2M.
This profile gathers the share dealings of David Milligan V across 3 companies, led by Caliper Life Sciences Inc, Madrigal Pharmaceuticals, Inc. and Icos Corp. The record holds 11 filings, for trades running from 11 May 2006 to 21 November 2018.
On the market, this insider has only sold: 2 sales, €3.1M in total. The rest of the record consists of 1 share grant and 6 option exercises. In 2020 alone, the filings show no purchases and 2 sales.
Most recently, on 26 February 2020, the filings show an open-market sale worth €1.2M in Madrigal Pharmaceuticals, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations